UPDATE 1-Takeda to make flu vaccines with Baxter's help - Nikkei
Fri Jun 18, 2010 2:14pm EDTStocks
June 19 (Reuters) - Japan's largest drugmaker Takeda Pharmaceutical Co (4502.T) will resume production of influenza vaccines after more than a decade, using technology from U.S. firm Baxter International Inc (BAX.N), the Nikkei business daily reported.
....
The Osaka-based firm will initially develop a vaccine to immunize against H5N1 avian flu, it said.
After clearing the new vaccine through clinical trials, Takeda will begin mass production and is expected to build up capacity to turn out enough vaccine for at least 40 million people, the daily said.
....
Fri Jun 18, 2010 2:14pm EDTStocks
June 19 (Reuters) - Japan's largest drugmaker Takeda Pharmaceutical Co (4502.T) will resume production of influenza vaccines after more than a decade, using technology from U.S. firm Baxter International Inc (BAX.N), the Nikkei business daily reported.
....
The Osaka-based firm will initially develop a vaccine to immunize against H5N1 avian flu, it said.
After clearing the new vaccine through clinical trials, Takeda will begin mass production and is expected to build up capacity to turn out enough vaccine for at least 40 million people, the daily said.
....
Comment